ANTIVIRAL MEDICATION - NASAL DROPS Russian patent published in 2011 - IPC A61K38/21 A61K47/10 A61K47/12 A61K47/30 A61P31/00 

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to field of pharmaceutics and represents antiviral medication, which contains genetically engineered interferon, polyvinyl pyrrolidone or polyethylene oxide, antioxidant and buffer mixture, which is characterised by the fact that it contains preliminarily mixed with hydroxypropylmethylcellulose polyvinyl pyrrolidone with weight ratio 1:1-100, 2% water solution of L-lysine hydrochloride and glycerin, components in medication are in specified ratio in 1 ml of buffer mixture in g.

EFFECT: invention insures increase of therapeutic efficiency due to prolonged action of medication by increasing duration of contact time between medication and mucous membrane, as well as makes it possible to reduce therapy course duration and increase of remission period to 6 months in case of chronic infectious diseases.

13 cl, 13 ex